Morningstar

Straumann Holding AG STMN

Morningstar Rating
Unlock
Stock XSWX Rating as of
CHF 135.60 −2.70 (1.95%)
View Full Chart
As of Delayed Price Open

Company Report

View Archive

Straumann's Operational Prowess and Market-Leading Portfolio Offsets Macro Challenges

Keonhee Kim

Straumann is a global leader in dental implants, a market that is estimated to be worth about CHF 6.0 billion. With decades of experience, Straumann is frequently ranked as the most credible and trusted dental implant brand in the world. Today, the leading five companies hold about three quarters of the implant market, with the remaining space shared among several hundred local players.

Read Full Report

Price vs Fair Value

View History
STMN is trading within a range we consider fairly valued.
Price
CHF 138.30
Fair Value
CHF 154.00
Uncertainty
Medium
1-Star Price
CHF 574.40
5-Star Price
CHF 83.90
Economic Moat
Wrcyj
Capital Allocation
Ftfcmcks

Bulls Say, Bears Say

Bulls

Straumann is making strategic acquisitions in high-growth markets.

Bears

Straumann might lose China market share because of volume-based procurement, which would have an adverse impact on more than half of sales in Asia-Pacific.

Show More

Trading Information

Previous Close Price
CHF 138.30
Day Range
CHF 134.80–138.25
52-Week Range
CHF 97.00–151.50
Bid/Ask
CHF 135.55 / CHF 135.60
Market Cap
CHF 21.61 Bil
Volume/Avg
81,446 / 319,377

Key Statistics

Price/Earnings (Normalized)
42.98
Price/Sales
8.94
Dividend Yield (Trailing)
0.61%
Dividend Yield (Forward)
0.61%
Total Yield
0.66%

Company Profile

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company’s core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
11,145
Website
https://www.straumann-group.com

Competitors

Valuation

View More
Metric
STMN
ALGN
XRAY
Price/Earnings (Normalized)
 42.9826.1313.59
Price/Book Value
 11.204.731.65
Price/Sales
 8.944.581.34
Price/Cash Flow
 33.4021.6411.62
Price/Earnings
STMN
ALGN
XRAY

Financial Strength

Metric
STMN
ALGN
XRAY
Quick Ratio
 1.310.980.66
Current Ratio
 2.111.181.33
Interest Coverage
 9.53—−0.68
Quick Ratio
STMN
ALGN
XRAY

Profitability

Metric
STMN
ALGN
XRAY
Return on Assets (Normalized)
 13.75%11.85%2.66%
Return on Equity (Normalized)
 24.67%19.67%5.78%
Return on Invested Capital (Normalized)
 18.85%18.68%4.56%
Return on Assets
STMN
ALGN
XRAY

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LngptnrmMmjb$172.9 Bil
 Becton Dickinson & Co
BDX
SrpphmkSytsv$69.3 Bil
 Alcon Inc
ALC
QqmgzsmcHwptd$49.2 Bil
 ResMed Inc
RMD
LlkmsxnvwMyzjdrg$35.1 Bil
 Coloplast AS ADR
CLPBY
QxdxfnxppCsj$29.2 Bil
 West Pharmaceutical Services Inc
WST
QffckzdcpJjsn$21.7 Bil
 The Cooper Companies Inc
COO
RzgzdvfhyBjshk$21.5 Bil
 Hologic Inc
HOLX
KkkpvqfyQxbglc$18.5 Bil
 Baxter International Inc
BAX
BwplvdxfpFwmsz$18.4 Bil
 Align Technology Inc
ALGN
FktqbrdPynmzbx$17.8 Bil

Sponsor Center